8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Macular Degeneration in 1 studies
8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively
Macular Degeneration: Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thampi, P | 1 |
| Rao, HV | 1 |
| Mitter, SK | 1 |
| Cai, J | 1 |
| Mao, H | 1 |
| Li, H | 1 |
| Seo, S | 1 |
| Qi, X | 1 |
| Lewin, AS | 1 |
| Romano, C | 1 |
| Boulton, ME | 1 |
1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Macular Degeneration
| Article | Year |
|---|---|
The 5HT1a receptor agonist 8-Oh DPAT induces protection from lipofuscin accumulation and oxidative stress in the retinal pigment epithelium.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aged; Aged, 80 and over; Animals; Antioxidants; Cell Line; C | 2012 |